pcDNA3-Flag-Smad4 Citations (4)

Originally described in: Functional consequences of tumorigenic missense mutations in the amino-terminal domain of Smad4.
Moren A, Itoh S, Moustakas A, Dijke P, Heldin CH Oncogene. 2000 Sep 7;19(38):4396-404. PubMed Journal

---

Articles Citing pcDNA3-Flag-Smad4

Articles
FOXC1 Regulates FGFR1 Isoform Switching to Promote Invasion Following TGFbeta-induced EMT. Hopkins A, Coatham ML, Berry FB. Mol Cancer Res. 2017 Jul 6. pii: molcanres.0185.2017. doi: 10.1158/1541-7786.MCR-17-0185. PubMed
SMAD4 Gene Mutation Renders Pancreatic Cancer Resistance to Radiotherapy through Promotion of Autophagy. Wang F, Xia X, Yang C, Shen J, Mai J, Kim HC, Kirui D, Kang Y, Fleming JB, Koay EJ, Mitra S, Ferrari M, Shen H. Clin Cancer Res. 2018 Jul 1;24(13):3176-3185. doi: 10.1158/1078-0432.CCR-17-3435. Epub 2018 Mar 30. PubMed
SMAD family member 3 (SMAD3) and SMAD4 repress HIF2alpha-dependent iron-regulatory genes. Ma X, Das NK, Castillo C, Gourani A, Perekatt AO, Verzi MP, Shah YM. J Biol Chem. 2019 Mar 15;294(11):3974-3986. doi: 10.1074/jbc.RA118.005549. Epub 2019 Jan 18. PubMed
Smad4 promotes diabetic nephropathy by modulating glycolysis and OXPHOS. Li J, Sun YBY, Chen W, Fan J, Li S, Qu X, Chen Q, Chen R, Zhu D, Zhang J, Wu Z, Chi H, Crawford S, Oorschot V, Puelles VG, Kerr PG, Ren Y, Nilsson SK, Christian M, Tang H, Chen W, Bertram JF, Nikolic-Paterson DJ, Yu X. EMBO Rep. 2020 Feb 5;21(2):e48781. doi: 10.15252/embr.201948781. Epub 2020 Jan 9. PubMed

If you have published an article using this material, please email us at to have your article added to this page.